Fair Value Calculator Fair Value Calculator
EN DE

IFGLEXPOR (IFGLEXPOR) Fair Value & Analysis

Basic Materials · Market cap ₹15.1B

I IFGLEXPOR IFGLEXPOR · NSE
Price₹208.95
Fair Value₹81.84
Upside-60.8%
Quality47/100
Watch IFGLEXPOR for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹61.38 – ₹100.41

Fair value as of: Jul 3, 2026

From 17 valuation models · updated today

Share price +7.5% over the past month.

Price vs Fair Value (12 months)

₹303.00 ₹123.00 Fair Value ₹81.84 Jul 2025 Jul 2026

12‑month range ₹123.00 – ₹303.00 · fair‑value band ₹61.38 – ₹100.41 · the ₹208.95 price screens above the ₹81.84 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

IFGLEXPOR (IFGLEXPOR) currently trades at ₹208.95, while our model-based Fair Value estimate is ₹81.84 — implying the stock looks roughly 60.8% overvalued today. We read business quality at 47/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, IFGLEXPOR generated revenue of ₹18.9B at a net margin of 1.8%. Revenue grew 7.7% year over year. It earns a return on equity of 3.0%. Net debt stands at ₹1.5B. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) ₹18.9B
Revenue growth (YoY) +7.7%
Net margin 1.8%
Return on equity 3.0%
Free cash flow −₹145M FY2026
P/E ratio 43.4
More key figures
Operating margin 3.8%
EPS (TTM) ₹4.81
EPS growth (YoY) +69.3%
Net debt ₹1.5B FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

IFGLEXPOR reported revenue of ₹18.9B in FY2026 versus ₹12.4B in FY2022, a compound +11.2%/yr. Reported net income was ₹347M in FY2026, compounding −18.2%/yr from FY2022.

Revenue +11.2%/yr
FY22 ₹12.4B
FY23 ₹13.7B
FY24 ₹16.3B
FY25 ₹16.7B
FY26 ₹18.9B
Net income −18.2%/yr
FY22 ₹775M
FY23 ₹792M
FY24 ₹817M
FY25 ₹430M
FY26 ₹347M

Is IFGLEXPOR fairly valued? → Check now

Similar stocks

6 more Building Materials stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock Price Fair Value vs Fair Value
CRH plc CRH $110.28 $70.25 -36%
Holcim AG HCMLY $19.20 $8.68 -55%
Heidelberg Materials AG HEI €190.80 €134.98 -29%
Vulcan Materials Company VMC $299.09 $119.01 -60%
Martin Marietta Materials, Inc MLM $575.83 $135.46 -76%
UltraTech Cement Limited ULTRACEMCO ₹10,866 ₹4,589 -58%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is IFGLEXPOR (IFGLEXPOR) undervalued?
As of Jul 3, 2026, our model estimates a fair value of ₹81.84 versus a price of ₹208.95 — about −61% (overvalued). Model-based estimate, not financial advice.
What is the fair value of IFGLEXPOR?
Our model-based fair value for IFGLEXPOR is ₹81.84 (as of Jul 3, 2026), built from audited fundamentals. The current price is ₹208.95.
What is the quality score of IFGLEXPOR?
IFGLEXPOR has a Quality Score of 47/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of IFGLEXPOR (IFGLEXPOR)?
IFGLEXPOR reported trailing-twelve-month revenue of about ₹18.9B (latest available figure, as of Jul 3, 2026).
What is the net profit margin of IFGLEXPOR?
The net profit margin of IFGLEXPOR is about 1.8%, meaning it keeps roughly 1.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.